Elisa Peranzoni

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Cells

Cancer immunology research

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Anaïs Vermare, Marion V Guerin, Elisa Peranzoni, Nadège Bercovici
Dynamic CD8 + T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy. Cancers 14 (14) (2022)
Clara Daher, Lene Vimeux, Ralitsa Stoeva, Elisa Peranzoni, Georges Bismuth, Elisabeth Wieduwild, Bruno Lucas, Emmanuel Donnadieu, Nadège Bercovici, Alain Trautmann, Vincent Feuillet
Blockade of β-Adrenergic Receptors Improves CD8+ T-cell Priming and Cancer Vaccine Efficacy. Cancer immunology research 7 (11) (2019)
Emeric Limagne, Marion Thibaudin, Lisa Nuttin, Aodrenn Spill, Valentin Derangère, Jean-David Fumet, Nadia Amellal, Elisa Peranzoni, Valérie Cattan, François Ghiringhelli
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages. Cancer immunology research 7 (12) (2019)

Elisa Peranzoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisa Peranzoni